Mindray Insulin (CLIA) Reagent Kit

Mindray Insulin (CLIA) Reagent Kit is an in vitro diagnostic chemiluminescence immunoassay reagent designed for the quantitative determination of insulin in human serum or plasma using compatible Mindray CL-series automatic chemiluminescence immunoassay analyzers. Mindray includes Insulin within its diabetes CLIA assay menu. Insulin is a peptide hormone produced by pancreatic beta cells and plays a central role in glucose metabolism. Laboratory insulin measurement can assist in evaluating insulin secretion, pancreatic beta-cell function, insulin resistance, diabetes mellitus and hypoglycaemic disorders. Mindray specifically notes that insulin testing may help identify insulin resistance and assess endogenous insulin production. Key Features - Quantitative determination of human insulin - Uses chemiluminescence immunoassay technology - Suitable for human serum or plasma - Compatible with Mindray CL-series analyzers - Liquid, ready-to-use reagent system - Available in 2 × 50 tests and 2 × 100 tests - Suitable for diabetes and metabolic assessment - Supports evaluation of insulin secretion and beta-cell function - Mindray states the assay is standardized against WHO International Standard Insulin 66/304 - Reported precision performance of CV below 4% in Mindray’s diabetes solution documentation - Intended for professional in vitro diagnostic use